Atlas Trials

Arthrosi Therapeutics

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Arthrosi Therapeutics

RecordFirmDate
Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients (NCT07116746)Arthrosi Therapeutics2025-12-03
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) (NCT06846515)Arthrosi Therapeutics2025-03-11
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302) (NCT06439602)Arthrosi Therapeutics2024-06-26
Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout (NCT05253833)Arthrosi Therapeutics2022-08-12
Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients (NCT05119686)Arthrosi Therapeutics2021-11-16
Pharmacokinetic Study of AR882 in Subjects With Various Degrees of Renal Impairment (NCT04646889)Arthrosi Therapeutics2021-01-14
Single-dose AME Study With [14C]AR882 in Healthy Male Subjects (NCT04508426)Arthrosi Therapeutics2020-07-16
Multiple Ascending Dose Study of AR882 in Healthy Adult Male Volunteers (NCT04314986)Arthrosi Therapeutics2019-06-28
The Study is Designed to Evaluate Single Ascending Doses of AR882 in Healthy Adult Males (NCT04347005)Arthrosi Therapeutics2019-01-22

Track Arthrosi Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.